|Systematic (IUPAC) name|
|Mol. mass||315.2085 g/mol|
2C-B-BZP is 2-bromo-4,5-dimethoxy-benzylpiperazine. It is related to BZP and shares the ring-substitution pattern of the psychedelic phenethylamine 2C-B, although 2C-B-BZP is not a phenethylamine itself.
Reported doses are mainly in the 100-200 mg range.
2C-B-BZP produces stimulant effects that last 3-6 hours, depending on the dose. Despite its structural similarity to 2C-B it does not produce psychedelic effects as the binding groups are in the wrong position to activate the 5HT2A receptor. 2C-B-BZP is also said by several sources to increase the effects of other compounds when combined. Side effects include headaches and nausea, similar to other piperazine derivatives used recreationally.
2C-B-BZP is unscheduled and uncontrolled in the United States, but possession and sales of 2C-B-BZP could possibly be prosecuted under the Federal Analog Act because of its structural similarities to 2C-B or BZP. 2C-B-BZP is said to be illegal to posses, use or sale in Japan where it used to be sold in local smartshops.
The pharmacology of 2C-B-BZP is unknown.
The toxicity of 2C-B-BZP is not known, although Benzylpiperazine (BZP), which is chemically related, has known toxicity.